The results of this study suggest that the age-related decline in cardiac Sesn2 levels is attributed to more detrimental cardiac outcomes in CRS3 and that metformin can provide cardiac structural and functional protection against AKI stress through Sesn2. The gene discussed is SESN2; the disease is acute kidney injury.